Načítá se...
Effects of octreotide on hepatic glycogenesis in rats with high fat diet-induced obesity
Reduced hepatic glycogenesis is one of the most important causes of metabolic abnormalities in non-alcoholic fatty liver disease. Octreotide, a somatostatin analogue, has been demonstrated to promote weight loss and improve metabolic disorders in mice with high fat diet (HFD)-induced obesity. Howeve...
Uloženo v:
| Vydáno v: | Mol Med Rep |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482138/ https://ncbi.nlm.nih.gov/pubmed/28534956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.6586 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|